Neural stem cells, neural progenitors, and neurotrophic factors
- PMID: 17474295
Neural stem cells, neural progenitors, and neurotrophic factors
Abstract
Neural stem cells (NSCs) have been proposed as a promising cellular source for the treatment of diseases in nervous systems. NSCs can self-renew and generate major cell types of the mammalian central nervous system throughout adulthood. NSCs exist not only in the embryo, but also in the adult brain neurogenic region: the subventricular zone (SVZ) of the lateral ventricle. Embryonic stem (ES) cells acquire NSC identity with a default mechanism. Under the regulations of leukemia inhibitory factor (LIF) and fibroblast growth factors, the NSCs then become neural progenitors. Neurotrophic and differentiation factors that regulate gene expression for controlling neural cell fate and function determine the differentiation of neural progenitors in the developing mammalian brain. For clinical application of NSCs in neurodegenerative disorders and damaged neurons, there are several critical problems that remain to be resolved: 1) how to obtain enough NSCs from reliable sources for autologous transplantation; 2) how to regulate neural plasticity of different adult stem cells; 3) how to control differentiation of NSCs in the adult nervous system. In order to understand the mechanisms that control NSC differentiation and behavior, we review the ontogeny of NSCs and other stem cell plasticity of neuronal differentiation. The role of NSCs and their regulation by neurotrophic factors in CNS development are also reviewed.
Similar articles
-
Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.BMC Neurosci. 2004 Oct 28;5:41. doi: 10.1186/1471-2202-5-41. BMC Neurosci. 2004. PMID: 15511288 Free PMC article.
-
The heterogeneity of adult neural stem cells and the emerging complexity of their niche.Cold Spring Harb Symp Quant Biol. 2008;73:357-65. doi: 10.1101/sqb.2008.73.019. Epub 2008 Nov 6. Cold Spring Harb Symp Quant Biol. 2008. PMID: 19022766 Review.
-
Expression profile of an operationally-defined neural stem cell clone.Exp Neurol. 2005 Aug;194(2):320-32. doi: 10.1016/j.expneurol.2005.04.018. Exp Neurol. 2005. PMID: 15992799
-
Stem cell biology of the central nervous system.J Neurosci Res. 2002 Sep 15;69(6):698-707. doi: 10.1002/jnr.10343. J Neurosci Res. 2002. PMID: 12205662 Review.
-
[Neural stem cells: the basic biology and prospects for brain repair].Nihon Shinkei Seishin Yakurigaku Zasshi. 2000 Feb;20(1):21-6. Nihon Shinkei Seishin Yakurigaku Zasshi. 2000. PMID: 10890020 Review. Japanese.
Cited by
-
Stem cells in drug screening for neurodegenerative disease.Korean J Physiol Pharmacol. 2012 Feb;16(1):1-9. doi: 10.4196/kjpp.2012.16.1.1. Epub 2012 Feb 28. Korean J Physiol Pharmacol. 2012. PMID: 22416213 Free PMC article.
-
Stem Cell Therapies for Central Nervous System Trauma: The 4 Ws-What, When, Where, and Why.Stem Cells Transl Med. 2022 Mar 3;11(1):14-25. doi: 10.1093/stcltm/szab006. Stem Cells Transl Med. 2022. PMID: 35641168 Free PMC article. Review.
-
An update on spinal cord injury research.Neurosci Bull. 2013 Feb;29(1):94-102. doi: 10.1007/s12264-012-1277-8. Epub 2012 Nov 3. Neurosci Bull. 2013. PMID: 23124646 Free PMC article. Review.
-
Stem Cell Therapies for Cerebral Palsy and Autism Spectrum Disorder-A Systematic Review.Brain Sci. 2021 Dec 3;11(12):1606. doi: 10.3390/brainsci11121606. Brain Sci. 2021. PMID: 34942908 Free PMC article. Review.
-
Unraveling the Mechanisms of Clinical Drugs-Induced Neural Tube Defects Based on Network Pharmacology and Molecular Docking Analysis.Neurochem Res. 2022 Dec;47(12):3709-3722. doi: 10.1007/s11064-022-03717-7. Epub 2022 Aug 12. Neurochem Res. 2022. PMID: 35960485
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical